Transforming the Future of Rural Healthcare in China
Through a data-driven approach and validated results, we are closing the urban-rural healthcare gap.
Closing the 50% Early Detection Gap
In rural China, the late-stage diagnosis rate for breast cancer is 50% higher than in urban areas. This gap translates to:
Poorer Prognoses
Late diagnosis significantly reduces treatment success and survival rates.
Higher Treatment Costs
Late-stage treatment can be 3-5 times more expensive than early-stage care.
Family Burden
Creates immense financial and emotional strain on rural families.
Patient Journey Comparison
Urban Woman
Rural Woman
Curascan's Mission: Change this trajectory by training local doctors.
Validated by Experts, Proven in Trials
Our platform's efficacy is not just a promise; it's proven. We have initiated clinical trials in rural Chinese hospitals to validate our impact in real-world settings.
Increase in Diagnostic Accuracy
Achieved in user trials, demonstrating the platform's core effectiveness.
Improvement in Early Tests
Observed in initial tests with medical students from partner universities like Shanghai Jiao Tong University.
"Curascan provides a diversity of cases simply not seen outside of major urban hospitals. It's an essential tool for the next generation of physicians."
Dr. Wei Li
Collaborating Radiologist, Shanghai Jiao Tong University Hospital
Our Partners in Impact
Shanghai Jiao Tong University
Peking Union Medical College
Chinese Medical Association
Healthy China 2030
Our Growing Impact
Healthcare Professionals Trained
Provinces Covered
Potential Patients Benefited
Be a Part of the Change
Join us in creating a healthier future for women in rural China.